Spectral AI (MDAI) Cash from Financing Activities (2021 - 2026)
Spectral AI (MDAI) posted Cash from Financing Activities of -$1000.0 for Q1 2026, down 100.01% on a QoQ basis from $7.4 million in Q4 2025, and down 100.01% year-over-year from $10.4 million in Q1 2025.
Spectral AI (MDAI) Cash from Financing Activities (2021 - 2026) Analysis & Trends
Spectral AI's Cash from Financing Activities history runs 6 years deep, the most recent figure standing at -$1000.0 for Q1 2026.
- Quarterly Cash from Financing Activities fell 100.01% year-over-year to -$1000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.7 million (down 18.38% YoY) and the FY2025 annual result came in at $20.1 million, up 110.13% from the prior year.
- Cash from Financing Activities was -$1000.0 for Q1 2026 at Spectral AI, down from $7.4 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $10.4 million in Q1 2025 and bottomed at -$1.6 million in Q3 2024.
- A 5-year average of $2.4 million and a median of $503500.0 in 2024 frame the typical range for Cash from Financing Activities.
- Peak annual rise in Cash from Financing Activities reached 7839.42% in 2024, while the deepest fall reached 134.6% in 2024.
- Spectral AI's Cash from Financing Activities stood at -$134000.0 in 2022, then tumbled by 45.52% to -$195000.0 in 2023, then jumped by 616.92% to $1.0 million in 2024, then soared by 639.09% to $7.4 million in 2025, then slumped by 100.01% to -$1000.0 in 2026.
- Business Quant data shows MDAI's Cash from Financing Activities at -$1000.0 in Q1 2026, $7.4 million in Q4 2025, and $2.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -25.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -26.93 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Spectral AI | 52.08 Mn | 40.43 Mn | 2.03 Mn | -1,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,000.00 |
| Mar 31, 2026 | -1,000.00 |
| Dec 31, 2025 | 7.45 Mn |
| Dec 31, 2025 | 7.45 Mn |
| Sep 30, 2025 | 2.49 Mn |
| Sep 30, 2025 | 2.49 Mn |
| Jun 30, 2025 | -207,000.00 |
| Jun 30, 2025 | -207,000.00 |
| Mar 31, 2025 | 10.39 Mn |
| Mar 31, 2025 | 10.39 Mn |
| Dec 31, 2024 | 1.01 Mn |
| Dec 31, 2024 | 1.01 Mn |
| Sep 30, 2024 | -1.56 Mn |
| Sep 30, 2024 | -1.56 Mn |
| Jun 30, 2024 | 2.08 Mn |
| Jun 30, 2024 | 2.08 Mn |
| Mar 31, 2024 | 8.05 Mn |
| Mar 31, 2024 | 8.05 Mn |
| Dec 31, 2023 | -195,000.00 |
| Dec 31, 2023 | -195,000.00 |